SlideShare ist ein Scribd-Unternehmen logo
1 von 21
Downloaden Sie, um offline zu lesen
REPORT FROM ISUOG CONGRESS
IN SYDNEY 2013
To Mai Xuan Hong

Dr. To Mai Xuan Hong

1
1st trimester assessment of aneuploidy
• US markers
–
–
–
–

NT, NB, Facial angle
Doppler of DV (a-wave)*
Doppler of tricuspid valve*
Intra-cranial translucency (IT)*

• Biochemical markers
– Fß-hCG and PAPP-A

• Non-invasive prenatal test
(NIPT)
– Decision of invasive test in the
intermediate risk (<1/10-1/1000
followed CFTS)
Dr. To Mai Xuan Hong

2
1st trimester assessment of aneuploidy

Dr. To Mai Xuan Hong

3
1st trimester assessment of aneuploidy
• Oral presentations
– Screening for adverse pregnancy outcomes at 12ws
(Audibert, Francois)
– Combined first trimester biochemistry, NIPT or both?
(Johnson, Jo-An)
– Sequencing for NIPT: techniques, technologies,
applications and limitations (Johnson, Jo-An)
– First trimester screening for neural tube defect (Meaghen,
Simon)
Dr. To Mai Xuan Hong

4
1st trimester assessment of growth and Doppler
• Crown-rump length measurement
• Increased Uterine artery Doppler indices (PI
> 90th or 95th centile) associated with
–

Reduced fetal movement

–

Superimposed pre-eclampsia

–

SGA < 10th centile

–

SGA < 3rd centile

–

Still birth

• Low PAPP-A level (<0.3 MoM) or both of
PAPP-A and free ß-hCG (<0.5MoM)
– related to poor placentation (low birth weight and still birth)
Dr. To Mai Xuan Hong

5
1st trimester assessment of growth and Doppler
• Oral presentations
– Assessment of crown-rump length measurement variability (McLennan, Andrew)
– Clinical evaluation of a first trimester algorithm predicting the risk of
hypertension disease of pregnancy (Park, Felicity)
– First trimester screening of pregnancy complication (Hyett, Jon)
– Assessment of 1st trimester uterine artery pulsatility index in Hongkong Chinease
pregnant women(Sahota, Daljit)
– Pulsatility index of the uterine arteries between 11 and 13.6 weeks: comparison
of measurement by transvaginal and transabdominal Doppler ultrasound (Cafici,
Daniel)
– Reduced fetal movement at term association to first trimester uterine artery
Doppler assessment (G Pagani)
– Reduced fetal movement at term: association to first trimester PAPP-A level (G
Pagani)
– Outcomes in cases of low PAPP-A and free ß-hCG in maternal serum at 1st
trimester screening (Deloison)
Dr. To Mai Xuan Hong

6
2nd trimester assessment
• Ratio of prenasal thickness (PT) and nasal bone length (NBL) (Down
syndrome)
• Fetal facial shape
– Facial height (FH) and facial width (FW) (FH/FW ratio)
– Forehead assessment (Profile line) (Down syndrome)

• Short femur length associated with
– Chromosomal abnormalities
– SGA
– Early preterm delivery

• Increased 2nd trimester uterine artery Doppler indices (> 90th centile)
associated with placental dysfunction)
• Femoral metaphyseal-epiphyseal angle (> 130◦ in achondroplasia)
• Asymptomatic short cervix length is a predictor of intra-amniotic
inflammation
Dr. To Mai Xuan Hong

7
2nd trimester assessment

Dr. To Mai Xuan Hong

8
2nd trimester assessment
• Oral presentations
– The prenasal thickness to nasal bone length ratio: 2D versus 3D ultrasound (E
de Jong)
– Fetal facial shape: 3D study of height and width in the 2nd and 3rd trimester of
pregnancy (A De Boagent)
– Forehead assessment in normal and pathological fetuses by the fetal profile
line (E de Jong)
– Outcome of fetuses with short femur length detected at 2nd trimester
malformation scan: a national survey (JM Mathiesen)
– Reduced fetal movement at term: association to second trimester uterine
artery Doppler assessment (G Pagani)
– Femoral metaphyseal-epiphyseal angle: a new prenatal ultrasound finding in
achondroplasia (A Khalil)
– Non-invasive prediction of intra-amniotic infection and/or inflammation in
patient with cervical insufficiency or an asymptomatic short cervix (<15mm) (E
Jung)
Dr. To Mai Xuan Hong

9
IUGR: detection and management
• Late-onset IUGR = SGA+(EFW<P3, Abnormal
MCA-UtA-UA)
– Poor outcome (neonatal morbility)
– Possible choosing an induction

• TRUFFLE study (Trial of Umbilical and Fetal Flow
in Europe)
– Decision the best timing of delivery in preterm
pregnancies complicated IUGR
– Surveillance test: CTG, UA and DV Doppler

• Aortic intima-media thickness (aIMT) (> 0.8mm)
– Higher SBP and glomerular dysfuction Hong
Dr. To Mai Xuan

10
IUGR: detection and management
• Oral presentations
– Are all late-onset IUGR the same? (E Gratacos)
– Clinical lessons from the TRUFFLE study (C Bilardo)
– The use of charts in detecting late-onset IUGR (A
Papageorghiou)
– Prenatal scale for cardiovascular risk in IUGR (E Cosmi)

Dr. To Mai Xuan Hong

11
Cervical assessment
• Preterm delivery
– Intra-amniotic sludge

• Induction of labor
– TVS assessment
– Comparison of funneling,
length and Bishop’s score
Dr. To Mai Xuan Hong

12
Cervical assessment
• Oral presentations
– Intra-amniotic sludge observed at cervical ultrasound
and the risk of preterm delivery (F. Audibert)
– Sonographic funneling of uterine cervix as predictor
for success of labor induction (E Kim)
– Pre and post-ripening sonographic assessment of
cervix for predicting successful induction of labor (M
Cordoba)
Dr. To Mai Xuan Hong

13
Fetal neurosonography
• Probst Bundle
– Agenesis of the corpus callosum

• Pericallosal lipoma
– Shows in 3rd trimester
– Increased echogenicity in corpus callosum
– Invisualised corpus callosum

• MRI in conjunction with US
– www.fetalmri2014.org ( 15-20 Mars 2014,
Canada)
Dr. To Mai Xuan Hong

14
Fetal neurosonography
• Oral presentations
– Disorders of axonal guidance as visualised by fetal MRI
(D Prayer)
– Periventricular leukomalacia in fetus: prenatal imaging
and diagnostic features (D Pugash)
– US volume navigation with fusion MRI imaging: a
novel approach for prenatal diagnosis (G Malinger)
Dr. To Mai Xuan Hong

15
IOTA classification
(International Ovarian Tumor Analysis)

• Main IOTA model

Dr. To Mai Xuan Hong

16
Dr. To Mai Xuan Hong

17
Simple rule for identifying a benign or malignant tumor

Dr. To Mai Xuan Hong

18
Simple rule for identifying a benign or malignant tumor

Dr. To Mai Xuan Hong

19
IOTA classification
(International Ovarian Tumor Analysis)

• Oral presentations
– Predictive value of subjective assessment, IOTA simple
rule, IOTA logistic regression model 1 (LR1), Alcazar’s
GI-RAD model and risk of malignancy (RMI) model in
the preoperative discrimination of adnexal mass (A
Czekierdowski)
– The additive value of HE4 novel tumor marker to the
IOTA simple rules in the management of ovarian
masses (B Erdoli)
Dr. To Mai Xuan Hong

20
Thank you!

Dr. To Mai Xuan Hong

21

Weitere ähnliche Inhalte

Was ist angesagt?

Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancerWalid Ahmed
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS JalandharDr H.K. Cheema
 
Management of endometrial carcinoma
Management of endometrial carcinomaManagement of endometrial carcinoma
Management of endometrial carcinomaSailendra Parida
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancerJwanSalh
 
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Aboubakr Elnashar
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahAyub Medical College
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancerfitango
 
Dubai endom cancer march 2013 final
Dubai endom cancer march 2013 finalDubai endom cancer march 2013 final
Dubai endom cancer march 2013 finalTariq Mohammed
 
Endometrial cancer
Endometrial cancer Endometrial cancer
Endometrial cancer Shazia Iqbal
 
The Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian CancerThe Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian CancerSibley Memorial Hospital
 

Was ist angesagt? (20)

Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancer
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
 
Management of endometrial carcinoma
Management of endometrial carcinomaManagement of endometrial carcinoma
Management of endometrial carcinoma
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullah
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancer
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Dubai endom cancer march 2013 final
Dubai endom cancer march 2013 finalDubai endom cancer march 2013 final
Dubai endom cancer march 2013 final
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometrium
 
Endometrial cancer
Endometrial cancer Endometrial cancer
Endometrial cancer
 
Breast carcinoma by Dr. Aryan
Breast carcinoma by Dr. AryanBreast carcinoma by Dr. Aryan
Breast carcinoma by Dr. Aryan
 
The Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian CancerThe Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian Cancer
 

Ähnlich wie ISUOG Congress Report on 1st Trimester Aneuploidy Assessment

ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.pptANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt9459654457
 
PRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptxPRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptxAnandSGiri
 
Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...
Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...
Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...Rustem Celami
 
Decrease fetal movement.prof.salah
Decrease fetal movement.prof.salahDecrease fetal movement.prof.salah
Decrease fetal movement.prof.salahSalah Roshdy AHMED
 
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILENT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILEDrNisheethOza
 
REDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANI
REDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANIREDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANI
REDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...
Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...
Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...Apollo Hospitals
 
Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...
Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...
Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...Indraneel Jadhav
 
Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...
Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...
Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...AI Publications
 
Arteria Uterina Primer Trimestre Y Rciu
Arteria Uterina Primer Trimestre Y RciuArteria Uterina Primer Trimestre Y Rciu
Arteria Uterina Primer Trimestre Y RciuEliana Cordero
 
Placental Elastography in Intrauterine Growth Restriction: A Case–control Study
Placental Elastography in Intrauterine Growth Restriction: A Case–control StudyPlacental Elastography in Intrauterine Growth Restriction: A Case–control Study
Placental Elastography in Intrauterine Growth Restriction: A Case–control Studyasclepiuspdfs
 
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...Premier Publishers
 

Ähnlich wie ISUOG Congress Report on 1st Trimester Aneuploidy Assessment (20)

ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.pptANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
ANTENATAL_SCREENING_IN_FIRST_AND_SECOND_TRIMESTER.ppt
 
Intrapartum sonography
Intrapartum sonographyIntrapartum sonography
Intrapartum sonography
 
PRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptxPRENATAL_DIAGNOSIS[1].pptx
PRENATAL_DIAGNOSIS[1].pptx
 
Fetal therapy
Fetal therapyFetal therapy
Fetal therapy
 
Role of 3-Dimensional Sonohysterography in Infertility
Role of 3-Dimensional Sonohysterography in InfertilityRole of 3-Dimensional Sonohysterography in Infertility
Role of 3-Dimensional Sonohysterography in Infertility
 
Screening what tests when
Screening what tests whenScreening what tests when
Screening what tests when
 
Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...
Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...
Obstetrical Ultrasound Examination and Biochemical Markers as Contemporary To...
 
UOG Journal Club: Angiogenic Factors vs. Doppler Surveillance in the Predicti...
UOG Journal Club: Angiogenic Factors vs. Doppler Surveillance in the Predicti...UOG Journal Club: Angiogenic Factors vs. Doppler Surveillance in the Predicti...
UOG Journal Club: Angiogenic Factors vs. Doppler Surveillance in the Predicti...
 
Decrease fetal movement.prof.salah
Decrease fetal movement.prof.salahDecrease fetal movement.prof.salah
Decrease fetal movement.prof.salah
 
Dissertation
DissertationDissertation
Dissertation
 
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILENT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
 
REDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANI
REDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANIREDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANI
REDUCED FETAL MOVEMENTS - HOW TO PROCEED BY DR SHASHWAT JANI
 
Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...
Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...
Colour Doppler ultrasound in controlled ovarian stimulation with Intrauterine...
 
Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...
Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...
Prediction of Gestational Diabetes Mellitus and Hypertensive Disorders in Pre...
 
What’s new in Ante Natal Care ?
What’s new in Ante Natal Care ?What’s new in Ante Natal Care ?
What’s new in Ante Natal Care ?
 
Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...
Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...
Ultrasonographic Cervical Length Measurement at 10-14- and 20-24-weeks’ Gesta...
 
Arteria Uterina Primer Trimestre Y Rciu
Arteria Uterina Primer Trimestre Y RciuArteria Uterina Primer Trimestre Y Rciu
Arteria Uterina Primer Trimestre Y Rciu
 
Placental Elastography in Intrauterine Growth Restriction: A Case–control Study
Placental Elastography in Intrauterine Growth Restriction: A Case–control StudyPlacental Elastography in Intrauterine Growth Restriction: A Case–control Study
Placental Elastography in Intrauterine Growth Restriction: A Case–control Study
 
H053046047
H053046047H053046047
H053046047
 
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...
 

Mehr von hungnguyenthien

Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...hungnguyenthien
 
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...hungnguyenthien
 
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...hungnguyenthien
 
LUNG ULTRASOUND for COVID-19
LUNG ULTRASOUND  for COVID-19LUNG ULTRASOUND  for COVID-19
LUNG ULTRASOUND for COVID-19hungnguyenthien
 
H. pylori update 2019[863] Dr VÕ THỊ CHI MAI
H. pylori update 2019[863] Dr VÕ THỊ CHI MAIH. pylori update 2019[863] Dr VÕ THỊ CHI MAI
H. pylori update 2019[863] Dr VÕ THỊ CHI MAIhungnguyenthien
 
H pylori clin virulence-diag aspects, Dr VO THI CHI MAI
H pylori clin virulence-diag aspects, Dr VO THI CHI MAIH pylori clin virulence-diag aspects, Dr VO THI CHI MAI
H pylori clin virulence-diag aspects, Dr VO THI CHI MAIhungnguyenthien
 
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂNLAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂNhungnguyenthien
 
Evaluation of Hyperferritinemia in Diabetic Patients
Evaluation of Hyperferritinemia in Diabetic PatientsEvaluation of Hyperferritinemia in Diabetic Patients
Evaluation of Hyperferritinemia in Diabetic Patientshungnguyenthien
 
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTERABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTERhungnguyenthien
 
NECK CYSTS, Dr PHAM THI THANH XUAN
NECK CYSTS, Dr PHAM THI THANH XUANNECK CYSTS, Dr PHAM THI THANH XUAN
NECK CYSTS, Dr PHAM THI THANH XUANhungnguyenthien
 
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và csSWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cshungnguyenthien
 
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương GiangBIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Gianghungnguyenthien
 
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...hungnguyenthien
 
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...hungnguyenthien
 
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍMSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍhungnguyenthien
 
TIRADs ACR 2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
TIRADs ACR  2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh MinhTIRADs ACR  2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
TIRADs ACR 2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minhhungnguyenthien
 
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.hungnguyenthien
 
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINHCase 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINHhungnguyenthien
 
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢI
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢICase 422; TORSION of TESTIS, Dr PHAN THANH HẢI
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢIhungnguyenthien
 

Mehr von hungnguyenthien (20)

Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
 
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
 
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
 
LUNG ULTRASOUND for COVID-19
LUNG ULTRASOUND  for COVID-19LUNG ULTRASOUND  for COVID-19
LUNG ULTRASOUND for COVID-19
 
COVID-19
COVID-19COVID-19
COVID-19
 
H. pylori update 2019[863] Dr VÕ THỊ CHI MAI
H. pylori update 2019[863] Dr VÕ THỊ CHI MAIH. pylori update 2019[863] Dr VÕ THỊ CHI MAI
H. pylori update 2019[863] Dr VÕ THỊ CHI MAI
 
H pylori clin virulence-diag aspects, Dr VO THI CHI MAI
H pylori clin virulence-diag aspects, Dr VO THI CHI MAIH pylori clin virulence-diag aspects, Dr VO THI CHI MAI
H pylori clin virulence-diag aspects, Dr VO THI CHI MAI
 
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂNLAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
 
Evaluation of Hyperferritinemia in Diabetic Patients
Evaluation of Hyperferritinemia in Diabetic PatientsEvaluation of Hyperferritinemia in Diabetic Patients
Evaluation of Hyperferritinemia in Diabetic Patients
 
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTERABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
 
NECK CYSTS, Dr PHAM THI THANH XUAN
NECK CYSTS, Dr PHAM THI THANH XUANNECK CYSTS, Dr PHAM THI THANH XUAN
NECK CYSTS, Dr PHAM THI THANH XUAN
 
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và csSWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
 
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương GiangBIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
 
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
 
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
 
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍMSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
 
TIRADs ACR 2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
TIRADs ACR  2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh MinhTIRADs ACR  2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
TIRADs ACR 2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
 
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
 
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINHCase 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
 
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢI
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢICase 422; TORSION of TESTIS, Dr PHAN THANH HẢI
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢI
 

Kürzlich hochgeladen

ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 

Kürzlich hochgeladen (20)

ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 

ISUOG Congress Report on 1st Trimester Aneuploidy Assessment

  • 1. REPORT FROM ISUOG CONGRESS IN SYDNEY 2013 To Mai Xuan Hong Dr. To Mai Xuan Hong 1
  • 2. 1st trimester assessment of aneuploidy • US markers – – – – NT, NB, Facial angle Doppler of DV (a-wave)* Doppler of tricuspid valve* Intra-cranial translucency (IT)* • Biochemical markers – Fß-hCG and PAPP-A • Non-invasive prenatal test (NIPT) – Decision of invasive test in the intermediate risk (<1/10-1/1000 followed CFTS) Dr. To Mai Xuan Hong 2
  • 3. 1st trimester assessment of aneuploidy Dr. To Mai Xuan Hong 3
  • 4. 1st trimester assessment of aneuploidy • Oral presentations – Screening for adverse pregnancy outcomes at 12ws (Audibert, Francois) – Combined first trimester biochemistry, NIPT or both? (Johnson, Jo-An) – Sequencing for NIPT: techniques, technologies, applications and limitations (Johnson, Jo-An) – First trimester screening for neural tube defect (Meaghen, Simon) Dr. To Mai Xuan Hong 4
  • 5. 1st trimester assessment of growth and Doppler • Crown-rump length measurement • Increased Uterine artery Doppler indices (PI > 90th or 95th centile) associated with – Reduced fetal movement – Superimposed pre-eclampsia – SGA < 10th centile – SGA < 3rd centile – Still birth • Low PAPP-A level (<0.3 MoM) or both of PAPP-A and free ß-hCG (<0.5MoM) – related to poor placentation (low birth weight and still birth) Dr. To Mai Xuan Hong 5
  • 6. 1st trimester assessment of growth and Doppler • Oral presentations – Assessment of crown-rump length measurement variability (McLennan, Andrew) – Clinical evaluation of a first trimester algorithm predicting the risk of hypertension disease of pregnancy (Park, Felicity) – First trimester screening of pregnancy complication (Hyett, Jon) – Assessment of 1st trimester uterine artery pulsatility index in Hongkong Chinease pregnant women(Sahota, Daljit) – Pulsatility index of the uterine arteries between 11 and 13.6 weeks: comparison of measurement by transvaginal and transabdominal Doppler ultrasound (Cafici, Daniel) – Reduced fetal movement at term association to first trimester uterine artery Doppler assessment (G Pagani) – Reduced fetal movement at term: association to first trimester PAPP-A level (G Pagani) – Outcomes in cases of low PAPP-A and free ß-hCG in maternal serum at 1st trimester screening (Deloison) Dr. To Mai Xuan Hong 6
  • 7. 2nd trimester assessment • Ratio of prenasal thickness (PT) and nasal bone length (NBL) (Down syndrome) • Fetal facial shape – Facial height (FH) and facial width (FW) (FH/FW ratio) – Forehead assessment (Profile line) (Down syndrome) • Short femur length associated with – Chromosomal abnormalities – SGA – Early preterm delivery • Increased 2nd trimester uterine artery Doppler indices (> 90th centile) associated with placental dysfunction) • Femoral metaphyseal-epiphyseal angle (> 130◦ in achondroplasia) • Asymptomatic short cervix length is a predictor of intra-amniotic inflammation Dr. To Mai Xuan Hong 7
  • 8. 2nd trimester assessment Dr. To Mai Xuan Hong 8
  • 9. 2nd trimester assessment • Oral presentations – The prenasal thickness to nasal bone length ratio: 2D versus 3D ultrasound (E de Jong) – Fetal facial shape: 3D study of height and width in the 2nd and 3rd trimester of pregnancy (A De Boagent) – Forehead assessment in normal and pathological fetuses by the fetal profile line (E de Jong) – Outcome of fetuses with short femur length detected at 2nd trimester malformation scan: a national survey (JM Mathiesen) – Reduced fetal movement at term: association to second trimester uterine artery Doppler assessment (G Pagani) – Femoral metaphyseal-epiphyseal angle: a new prenatal ultrasound finding in achondroplasia (A Khalil) – Non-invasive prediction of intra-amniotic infection and/or inflammation in patient with cervical insufficiency or an asymptomatic short cervix (<15mm) (E Jung) Dr. To Mai Xuan Hong 9
  • 10. IUGR: detection and management • Late-onset IUGR = SGA+(EFW<P3, Abnormal MCA-UtA-UA) – Poor outcome (neonatal morbility) – Possible choosing an induction • TRUFFLE study (Trial of Umbilical and Fetal Flow in Europe) – Decision the best timing of delivery in preterm pregnancies complicated IUGR – Surveillance test: CTG, UA and DV Doppler • Aortic intima-media thickness (aIMT) (> 0.8mm) – Higher SBP and glomerular dysfuction Hong Dr. To Mai Xuan 10
  • 11. IUGR: detection and management • Oral presentations – Are all late-onset IUGR the same? (E Gratacos) – Clinical lessons from the TRUFFLE study (C Bilardo) – The use of charts in detecting late-onset IUGR (A Papageorghiou) – Prenatal scale for cardiovascular risk in IUGR (E Cosmi) Dr. To Mai Xuan Hong 11
  • 12. Cervical assessment • Preterm delivery – Intra-amniotic sludge • Induction of labor – TVS assessment – Comparison of funneling, length and Bishop’s score Dr. To Mai Xuan Hong 12
  • 13. Cervical assessment • Oral presentations – Intra-amniotic sludge observed at cervical ultrasound and the risk of preterm delivery (F. Audibert) – Sonographic funneling of uterine cervix as predictor for success of labor induction (E Kim) – Pre and post-ripening sonographic assessment of cervix for predicting successful induction of labor (M Cordoba) Dr. To Mai Xuan Hong 13
  • 14. Fetal neurosonography • Probst Bundle – Agenesis of the corpus callosum • Pericallosal lipoma – Shows in 3rd trimester – Increased echogenicity in corpus callosum – Invisualised corpus callosum • MRI in conjunction with US – www.fetalmri2014.org ( 15-20 Mars 2014, Canada) Dr. To Mai Xuan Hong 14
  • 15. Fetal neurosonography • Oral presentations – Disorders of axonal guidance as visualised by fetal MRI (D Prayer) – Periventricular leukomalacia in fetus: prenatal imaging and diagnostic features (D Pugash) – US volume navigation with fusion MRI imaging: a novel approach for prenatal diagnosis (G Malinger) Dr. To Mai Xuan Hong 15
  • 16. IOTA classification (International Ovarian Tumor Analysis) • Main IOTA model Dr. To Mai Xuan Hong 16
  • 17. Dr. To Mai Xuan Hong 17
  • 18. Simple rule for identifying a benign or malignant tumor Dr. To Mai Xuan Hong 18
  • 19. Simple rule for identifying a benign or malignant tumor Dr. To Mai Xuan Hong 19
  • 20. IOTA classification (International Ovarian Tumor Analysis) • Oral presentations – Predictive value of subjective assessment, IOTA simple rule, IOTA logistic regression model 1 (LR1), Alcazar’s GI-RAD model and risk of malignancy (RMI) model in the preoperative discrimination of adnexal mass (A Czekierdowski) – The additive value of HE4 novel tumor marker to the IOTA simple rules in the management of ovarian masses (B Erdoli) Dr. To Mai Xuan Hong 20
  • 21. Thank you! Dr. To Mai Xuan Hong 21